Clinical Trial Update: A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating RO7200220 as monotherapy and in combination with ranibizumab in participants with diabetic macular edema and uveitic macular edema ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Uveitic Macular Edema

Drugs mentioned

• RO7200220
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema, Uveitic Macular Edema | Phase 1 | Status: COMPLETED